Serum 5-Hydroxytryptamine is Related to Psoriasis Severity in Patients with Comorbid Anxiety or Depression
DOI:
https://doi.org/10.2340/00015555-3857Keywords:
psoriasis, serum serotonin, anxiety, depression, effect modificationAbstract
Abstract is missing (Short communication)
Downloads
References
Banskota S, Ghia JE, Khan WI. Serotonin in the gut: blessing or a curse. Biochimie 2019; 161: 56–64.
Cohen BE, Martires KJ, Ho RS. Psoriasis and the risk of depression in the US population: National Health and Nutrition Examination Survey 2009–2012. JAMA Dermatol 2016; 152: 73–79.
Blier P, El Mansari M. Serotonin and beyond: therapeutics for major depression. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20120536.
O’Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 2015; 277: 32–48.
Matiushenko V, Kutasevych Y, Jafferany M. Neurotransmitter imbalance in serum of psoriatic patients in exacerbation stage with comorbid psychoemotional disorders. Dermatol Ther 2020; 33: e13337.
Ye X, Shu HL, Feng X, Xia DM, Wang ZQ, Mi WY, et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire-9 (C-PHQ-9) in patients with psoriasis: a cross-sectional study. BMJ Open 2020; 10: e033211.
Vallieres A, Bastien CH, Ouellet MC, Morin CM. Cognitive-behaviour therapy for insomnia associated with anxiety or depression. Sleep 2000; 23: 1–11.
Huang JG, Li GM, Lan YF. Determination of serum 5-hydroxytryptamine in patients with psoriasis. Chin J Dedrmatol 2000; 33: 118.
Younes SF, Bakry OA. Immunohistochemical evaluation of role of serotonin in pathogenesis of psoriasis. J Clin Diagn Res 2016; 10: EC05–EC09.
Martins AM, Ascenso A, Ribeiro HM, Marto J. The brain-skin connection and the pathogenesis of psoriasis: a review with a focus on the serotonergic system. Cells 2020; 9: 796.
Thorslund K, Amatya B, Dufva AE, Nordlind K. The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress. Arch Dermatol Res 2013; 305: 99–104.
Thorslund K, Svensson T, Nordlind K, Ekbom A, Fored CM. Use of serotonin reuptake inhibitors in patients with psoriasis is associated with a decreased need for systemic psoriasis treatment: a population-based cohort study. J Intern Med 2013; 274: 281–287.
Chen YH, Wang WM, Li IH, Kao HH, Yeh CB, Kao LT. Major depressive disorder increased risk of psoriasis: a propensity score matched cohort study. J Affect Disord 2021; 278: 407–412.
Tzeng YM, Li IH, Kao HH, Shih JH, Yeh CB, Chen YH, Kao LT. Protective effects of anti-depressants against the subsequent development of psoriasis in patients with major depressive disorder: a cohort study. J Affect Disord 2020; 281: 590–596.
Published
How to Cite
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
